Biotech

All Articles

ProKidney stops phase 3 trial certainly not needed for cell treatment authorization

.ProKidney has actually quit some of a pair of phase 3 tests for its cell treatment for kidney ailme...

Vaxcyte surges on 'spectacular' 31-valent PCV gain versus Pfizer

.Vaxcyte revealed what professionals referred to as "remarkable" period 1/2 records for its 31-valen...

Recursion's human brain disease trial reveals scant documentation of efficiency

.Recursion has stumbled by means of an early exam of its tech-enabled technique to medication explor...

Acepodia, Pfizer click all together for chemistry-based tissue therapy

.Phone it a situation of excellent chemical make up: Acepodia, a biotech based on Nobel Prize-winnin...

Praxis epilepsy drug reduces confiscations in period 2 litigation

.Practice Accuracy Medicines has racked up an additional midphase win in epilepsy this year, with it...

Three officers resign as Dyne articles combined information for DMD candidate

.After getting away a scientific grip numerous years back, Dyne Therapeutics has actually revealed b...

Arrowhead fires off phase 3 records in rare metabolic condition before market clash with Ionis

.Arrowhead Pharmaceuticals has presented its give in front of a possible face-off along with Ionis, ...

Pfizer, Valneva present lyme condition chance helpful for 2nd booster

.Pfizer as well as Valneva may possess regarding two additional years to wait before they produce th...

Fierce Biotech Editor-in-Chief Ayla Ellison Speaks Shop with Michelle Benz on the Future of Biotech.

.Permit's dive into a chat along with Ayla Ellison, Fierce Biotech Managing Editor and Michelle Benz...

New data show how Bayer's asundexian failed to prevent movements

.Bayer suspended the phase 3 trial for its factor XIa prevention asundexian late in 2015 after the m...